9 Meters Biopharma, Inc.
9 Meters Biopharma, Inc., headquartered in the United States, is a pioneering biotechnology company focused on developing innovative therapies for patients with rare gastrointestinal diseases. Founded in 2018, the company has quickly established itself in the biopharmaceutical industry, particularly in the areas of drug development and clinical research. With a robust pipeline that includes unique oral therapies, 9 Meters Biopharma is dedicated to addressing unmet medical needs in conditions such as short bowel syndrome and celiac disease. Their flagship product, a novel treatment for short bowel syndrome, showcases their commitment to advancing patient care through cutting-edge science. Recognised for its rapid progress and strategic partnerships, 9 Meters Biopharma is positioned as a leader in the biopharma sector, striving to improve the quality of life for patients worldwide.
DitchCarbon Score
How does 9 Meters Biopharma, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
9 Meters Biopharma, Inc.'s score of 18 is higher than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.
9 Meters Biopharma, Inc.'s reported carbon emissions
9 Meters Biopharma, Inc., headquartered in the US, currently does not have available carbon emissions data for the most recent year, nor do they have specified reduction targets or climate pledges. Without specific emissions figures or commitments, it is unclear how the company is addressing its carbon footprint or contributing to climate action within the biopharmaceutical industry. As the sector increasingly focuses on sustainability, 9 Meters Biopharma's future initiatives and commitments will be crucial in aligning with industry standards and expectations for reducing greenhouse gas emissions.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
9 Meters Biopharma, Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
